HC Wainwright & Co. Reiterates Buy on Icecure Medical, Maintains $3 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Icecure Medical (NASDAQ:ICCM) and maintained a $3 price target.
March 05, 2024 | 11:37 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. analyst Yi Chen reiterates a Buy rating on Icecure Medical with a $3 price target.
The reiteration of a Buy rating and maintenance of a $3 price target by a reputable analyst like Yi Chen could instill confidence among investors and potentially lead to a positive short term impact on Icecure Medical's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100